logo-loader

Arecor extends collaboration with top five pharmaceutical firm for new medicine formula

Published: 04:31 13 Feb 2020 EST

Arecor - Arecor extends collaboration with top five pharmaceutical firm for new medicine formula

Arecor Ltd has inked a further collaboration agreement with a top five pharmaceutical company to develop a liquid formulation of a ready-to-administer (RTA) medicine using its Arestat technology.

The biopharma group said its partner will fund a feasibility study into the formula and will retain an exclusive option to a global royalty bearing licence for the product and Arecor’s associated IP.

READ: Arecor signs agreement with Hikma Pharma to develop new injectable medicine

"This is the second RTA collaboration that we have announced in recent weeks involving our proprietary technology platform Arestat. It is a further project for an existing pharmaceutical partner which demonstrates the value of our technology and expertise together with the strength of our commercial relationships”, said Arecor chief executive Sarah Howell.

FTSE 100 awaits Rishi Sunak’s Budget today while oil majors rise with higher...

FTSE 100 opened higher helped by a strong start from the oil majors BP and Shell as more brokers predicted crude prices are going to rise higher. Attention will focus on Rishi Sunak’s Budget later today but for now the index is up 38 at 7,515.   Sunak’s announcement comes just after UK...

on 03/23/2022